We are live on
!
Find out more
Zurich Cantonal Bank Portfolio holdings
AUM
$46B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+24.78%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$11.6B
AUM Growth
+$916M
(+8.6%)
Cap. Flow
-$1.35B
Cap. Flow
% of AUM
-11.65%
Top 10 Holdings %
Top 10 Hldgs %
25.82%
Holding
2,683
New
78
Increased
1,314
Reduced
604
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$24.6M |
| 2 |
Oracle
ORCL
|
+$11.4M |
| 3 |
NiSource
NI
|
+$9.66M |
| 4 |
Alibaba
BABA
|
+$9.46M |
| 5 |
American Tower
AMT
|
+$8.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$86.6M |
| 2 |
Apple
AAPL
|
+$81.3M |
| 3 |
Amazon
AMZN
|
+$39.7M |
| 4 |
Mastercard
MA
|
+$30.2M |
| 5 |
Visa
V
|
+$28.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.63% |
| 2 | Financials | 15.69% |
| 3 | Healthcare | 14.58% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Communication Services | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
BioCryst Pharmaceuticals
BCRX
$2.64B
| $113K | ﹤0.01% |
23,789
+6,229
| +35% | +$24.9K |
|
1852
Heritage Financial
HFWA
$1.21B
| $113K | ﹤0.01% |
5,669
+1,709
| +43% | +$32.2K |
|
1853
Karyopharm Therapeutics
KPTI
$47.6M
| $113K | ﹤0.01% |
398
| – | – |
|
1854
Tredegar Corp
TG
$275M
| $113K | ﹤0.01% |
7,335
+5,777
| +371% | +$89.5K |
|
|
FOE
1855
DELISTED
Ferro Corporation
FOE
| $113K | ﹤0.01% |
9,433
| – | – |
|
1856
Oxford Industries
OXM
$542M
| $112K | ﹤0.01% |
2,544
+1,281
| +101% | +$53.3K |
|
1857
Trupanion
TRUP
$1.34B
| $112K | ﹤0.01% |
2,612
| – | – |
|
|
RCM
1858
DELISTED
R1 RCM Inc. Common Stock
RCM
| $112K | ﹤0.01% |
10,030
| – | – |
|
|
SRNE
1859
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $112K | ﹤0.01% |
+17,800
| New | +$68.1K |
|
1860
Abercrombie & Fitch
ANF
$5.24B
| $111K | ﹤0.01% |
10,447
+6,885
| +193% | +$75.1K |
|
1861
Bloomin' Brands
BLMN
$952M
| $111K | ﹤0.01% |
10,430
+4,826
| +86% | +$49.9K |
|
1862
Central Pacific Financial
CPF
$996M
| $111K | ﹤0.01% |
6,932
+5,164
| +292% | +$82K |
|
1863
Resideo Technologies
REZI
$3.67B
| $111K | ﹤0.01% |
9,436
| – | – |
|
1864
Regenxbio
RGNX
$703M
| $111K | ﹤0.01% |
3,001
| – | – |
|
1865
Sinclair Inc
SBGI
$989M
| $111K | ﹤0.01% |
6,020
| – | – |
|
1866
Schneider National
SNDR
$6.12B
| $111K | ﹤0.01% |
4,496
+1,004
| +29% | +$22.1K |
|
|
CMO
1867
DELISTED
Capstead Mortgage Corp.
CMO
| $111K | ﹤0.01% |
20,237
+10,873
| +116% | +$54.6K |
|
1868
Anterix
ATEX
$1.81B
| $110K | ﹤0.01% |
2,427
+582
| +32% | +$29.7K |
|
1869
NMI Holdings
NMIH
$3.34B
| $110K | ﹤0.01% |
6,869
+1,486
| +28% | +$21.1K |
|
1870
Vanda Pharmaceuticals
VNDA
$298M
| $110K | ﹤0.01% |
9,575
+5,699
| +147% | +$64.5K |
|
|
HTLF
1871
DELISTED
Heartland Financial USA, Inc.
HTLF
| $110K | ﹤0.01% |
3,287
| – | – |
|
1872
Calix
CALX
$2.49B
| $109K | ﹤0.01% |
+7,291
| New | +$83.7K |
|
1873
Encore Capital Group
ECPG
$1.98B
| $109K | ﹤0.01% |
3,191
+1,615
| +102% | +$48.1K |
|
1874
Innoviva
INVA
$1.5B
| $109K | ﹤0.01% |
7,762
+1,677
| +28% | +$22.8K |
|
1875
Phibro Animal Health
PAHC
$1.38B
| $108K | ﹤0.01% |
4,107
+1,283
| +45% | +$31.9K |
|
Similar funds
LP
TI
Zurich Cantonal Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Zurich Cantonal Bank held 2,683 positions worth $11.6B, up 8.6% from $10.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Zurich Cantonal Bank withdrew a net $1.35B in Q2 2020, closing 157 positions and reducing 604 holdings. Its most notable exit was Allergan plc, an estimated $25.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Zurich Cantonal Bank opened a new position in Otis Worldwide worth $5.72M.
- Zurich Cantonal Bank's largest Q2 2020 buy was Otis Worldwide: 100,656 shares worth $5.72M.
- Zurich Cantonal Bank added most to Aptiv in Q2 2020, an estimated $24.6M increase.
- Zurich Cantonal Bank's biggest Q2 2020 reduction was Microsoft, cutting an estimated $86.6M.
- Zurich Cantonal Bank fully exited Allergan plc in Q2 2020, selling an estimated $25.8M.
- Zurich Cantonal Bank's ten largest holdings make up 26% of its $11.6B portfolio in Q2 2020.
- Zurich Cantonal Bank opened 78 new positions and closed 157 in Q2 2020.
- Zurich Cantonal Bank's portfolio value rose 8.6% quarter-over-quarter to $11.6B.
Based on Zurich Cantonal Bank's 13F filing for Q2 2020, filed 28 Jul 2020.